Deciphera Pharmaceuticals, Inc. Announces Appointment of Susan L. Kelley, M.D., to its Board of Directors

44

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the appointment of Susan L. Kelley, M.D. to its Board of Directors. Dr. Kelley will serve as an independent director and member of the Compensation Committee. “It is a pleasure to welcome Susan to the Board of Directors at such an exciting time for Deciphera,” said Steve Hoerter, President and….

 

 

 

 

http://www.businesswire.com/news/home/20190708005706/en/Deciphera-Pharmaceuticals-Announces-Appointment-Susan-L.-Kelley